Trial intelligence / Profile preview

Dexmedetomidine with intravenous lidocaine in colonoscopy

IRCT20220706055402N2Phase 3Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
Jan 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of dexmedetomidine and lidocaine in anxiety disorder, sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Jan 2023; status: completed.

02

Drugs

dexmedetomidinelidocaine
03

Conditions

anxiety disorder

Beyond the preview

Go deeper on IRCT20220706055402N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220706055402N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call